September 13, 2022 Thomas R. Kassberg Re: Amendment No. 2 to Offer Letter Dear Tom:Ultragenyx Pharmaceutical Inc. • November 3rd, 2022 • Pharmaceutical preparations
Company FiledNovember 3rd, 2022 IndustryOn behalf of Ultragenyx Pharmaceutical Inc. (the “Company”), I am pleased to present to you this Amendment No. 2 (this “Amendment”), which amends the Offer of Employment Letter Agreement with you dated October 31, 2011 and as amended by Amendment No. 1 dated August 8, 2014 (collectively, the “Offer Letter”) as follows:
September 13, 2022 Dennis Huang Re: Amendment No. 1 to Offer Letter Dear Dennis:Ultragenyx Pharmaceutical Inc. • November 3rd, 2022 • Pharmaceutical preparations
Company FiledNovember 3rd, 2022 IndustryOn behalf of Ultragenyx Pharmaceutical Inc. (the “Company”), I am pleased to present to you this Amendment No. 1 (this “Amendment”), which amends the Offer of Employment Letter Agreement with you dated February 20, 2015 (the “Offer Letter”) as follows:
September 13, 2022 John Pinion II Re: Amendment No. 1 to Offer Letter Dear John:Ultragenyx Pharmaceutical Inc. • November 3rd, 2022 • Pharmaceutical preparations
Company FiledNovember 3rd, 2022 IndustryOn behalf of Ultragenyx Pharmaceutical Inc. (the “Company”), I am pleased to present to you this Amendment No. 1 (this “Amendment”), which amends the Offer of Employment Letter Agreement with you dated June 11, 2015 (the “Offer Letter”) as follows:
September 13, 2022 Camille Bedrosian M.D. Re: Amendment No. 1 to Offer Letter Dear Camille:Ultragenyx Pharmaceutical Inc. • November 3rd, 2022 • Pharmaceutical preparations
Company FiledNovember 3rd, 2022 IndustryOn behalf of Ultragenyx Pharmaceutical Inc. (the “Company”), I am pleased to present to you this Amendment No. 1 (this “Amendment”), which amends the Offer of Employment Letter Agreement with you dated January 15, 2018 (the “Offer Letter”) as follows: